199 related articles for article (PubMed ID: 32803282)
1. Safety and Tolerability of Topotecan-Eluting Radiopaque Microspheres for Hepatic Chemoembolization in a Rabbit Preclinical Model.
Mikhail AS; Levy EB; Krishnasamy VP; Woods DL; Esparza-Trujillo JA; Bakhutashvili I; Banovac F; Wakim PG; Negussie AH; Tang Y; Henman A; Willis SL; Karanian JW; Pritchard WF; Lewis AL; Wood BJ
Cardiovasc Intervent Radiol; 2020 Dec; 43(12):1918-1924. PubMed ID: 32803282
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy compared between irinotecan-loaded microspheres HepaSphere and DC bead in a model of VX2 liver metastases in the rabbit.
Namur J; Pascale F; Maeda N; Sterba M; Ghegediban SH; Verret V; Paci A; Seck A; Osuga K; Wassef M; Reb P; Laurent A
J Vasc Interv Radiol; 2015 Jul; 26(7):1067-1075.e3. PubMed ID: 25952641
[TBL] [Abstract][Full Text] [Related]
3. Mapping Drug Dose Distribution on CT Images Following Transarterial Chemoembolization with Radiopaque Drug-Eluting Beads in a Rabbit Tumor Model.
Mikhail AS; Pritchard WF; Negussie AH; Krishnasamy VP; Amchin DB; Thompson JG; Wakim PG; Woods D; Bakhutashvili I; Esparza-Trujillo JA; Karanian JW; Willis SL; Lewis AL; Levy EB; Wood BJ
Radiology; 2018 Nov; 289(2):396-404. PubMed ID: 30106347
[TBL] [Abstract][Full Text] [Related]
4. Irinotecan eluting beads-transarterial chemoembolization using Callispheres® microspheres is an effective and safe approach in treating unresectable colorectal cancer liver metastases.
Zhao G; Liu S; Zhang Y; Zhao T; Wang R; Bian J; Wu J; Zhou J
Ir J Med Sci; 2022 Jun; 191(3):1139-1145. PubMed ID: 34264426
[TBL] [Abstract][Full Text] [Related]
5. Safety, Efficacy and Distribution of Doxorubicin Loaded Radiopaque Beads in Chemoembolization in Intermediate Stage Hepatocellular Carcinoma (HCC) with Correlation with Local Response.
Malagari Κ; Kiakidis T; Moschouris H; Deutsch M; Tanteles S; Pantou E; Panagiotou I; Koskinas J; Glantzounis GK; Alexopoulou A; Filippiadis D; Brountzos E; Kelekis N
Cardiovasc Intervent Radiol; 2023 Mar; 46(3):337-349. PubMed ID: 36653660
[TBL] [Abstract][Full Text] [Related]
6. Selective TACE with irinotecan-loaded 40 μm microspheres and FOLFIRI for colorectal liver metastases: phase I dose escalation pharmacokinetic study.
Tanaka T; Sato T; Nishiofuku H; Masada T; Tatsumoto S; Marugami N; Otsuji T; Kanno M; Koyama F; Sho M; Kichikawa K
BMC Cancer; 2019 Aug; 19(1):758. PubMed ID: 31370815
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and antitumor efficacy of chemoembolization using 40 µm irinotecan-loaded microspheres in a rabbit liver tumor model.
Tanaka T; Nishiofuku H; Hukuoka Y; Sato T; Masada T; Takano M; Gilbert CW; Obayashi C; Kichikawa K
J Vasc Interv Radiol; 2014 Jul; 25(7):1037-1044.e2. PubMed ID: 24861663
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of TACE With Irinotecan-loaded Drug-eluting Beads (DEBIRI) in Patients With Liver Metastases from Unresectable Colorectal Cancer.
Ishikawa T; Imai M; Sato R; Jimbo R; Kobayashi Y; Sato T; Iwanaga A; Sano T; Yokoyama J; Honma T
Anticancer Res; 2023 Aug; 43(8):3647-3651. PubMed ID: 37500124
[TBL] [Abstract][Full Text] [Related]
9. The power of genes: a case of unusually severe systemic toxicity after localized hepatic chemoembolization with irinotecan-eluted microspheres for metastatic colon cancer.
Cruz JE; Saksena R; Jabbour SK; Nosher JL; Hermes-DeSantis E; Moss RA
Ann Pharmacother; 2014 Dec; 48(12):1646-50. PubMed ID: 25202035
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a novel intrinsically radiopaque Drug-eluting Bead for image-guided therapy: DC Bead LUMI™.
Ashrafi K; Tang Y; Britton H; Domenge O; Blino D; Bushby AJ; Shuturminska K; den Hartog M; Radaelli A; Negussie AH; Mikhail AS; Woods DL; Krishnasamy V; Levy EB; Wood BJ; Willis SL; Dreher MR; Lewis AL
J Control Release; 2017 Mar; 250():36-47. PubMed ID: 28188808
[TBL] [Abstract][Full Text] [Related]
11. Transarterial chemoembolization with DC Bead LUMI™ radiopaque beads for primary liver cancer treatment: preliminary experience.
Aliberti C; Carandina R; Sarti D; Pizzirani E; Ramondo G; Cillo U; Guadagni S; Fiorentini G
Future Oncol; 2017 Oct; 13(25):2243-2252. PubMed ID: 29063780
[TBL] [Abstract][Full Text] [Related]
12. DEB-TACE: a standard review.
Melchiorre F; Patella F; Pescatori L; Pesapane F; Fumarola E; Biondetti P; Brambillasca P; Monaco C; Ierardi AM; Franceschelli G; Carrafiello G
Future Oncol; 2018 Dec; 14(28):2969-2984. PubMed ID: 29987957
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors for overall survival and safety of trans-arterial chemoembolization (TACE) with irinotecan-loaded drug-eluting beads (DEBIRI) in patients with colorectal liver metastases.
Sljivic M; Sever M; Ocvirk J; Mesti T; Brecelj E; Popovic P
Radiol Oncol; 2024 Jun; 58(2):214-220. PubMed ID: 38553252
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of Combination Intra-arterial Yttrium-90 and Irinotecan Microspheres in the VX2 Rabbit Model.
Gordon AC; White SB; Yang Y; Gates VL; Procissi D; Harris KR; Zhang Z; Lyu T; Huang X; Dreher MR; Omary RA; Salem R; Lewandowski RJ; Larson AC
Cardiovasc Intervent Radiol; 2020 Oct; 43(10):1528-1537. PubMed ID: 32533312
[TBL] [Abstract][Full Text] [Related]
15. Comparison of DC Bead-irinotecan and DC Bead-topotecan drug eluting beads for use in locoregional drug delivery to treat pancreatic cancer.
Forster RE; Small SA; Tang Y; Heaysman CL; Lloyd AW; Macfarlane W; Phillips GJ; Antonijevic MD; Lewis AL
J Mater Sci Mater Med; 2010 Sep; 21(9):2683-90. PubMed ID: 20563626
[TBL] [Abstract][Full Text] [Related]
16. The CIREL Cohort: A Prospective Controlled Registry Studying the Real-Life Use of Irinotecan-Loaded Chemoembolisation in Colorectal Cancer Liver Metastases: Interim Analysis.
Pereira PL; Iezzi R; Manfredi R; Carchesio F; Bánsághi Z; Brountzos E; Spiliopoulos S; Echevarria-Uraga JJ; Gonçalves B; Inchingolo R; Nardella M; Pellerin O; Sousa M; Arnold D; de Baère T; Gomez F; Helmberger T; Maleux G; Prenen H; Sangro B; Zeka B; Kaufmann N; Taieb J
Cardiovasc Intervent Radiol; 2021 Jan; 44(1):50-62. PubMed ID: 32974773
[TBL] [Abstract][Full Text] [Related]
17. Intra-arterial hepatic chemoembolization (TACE) of liver metastases from ocular melanoma with slow-release irinotecan-eluting beads. Early results of a phase II clinical study.
Fiorentini G; Aliberti C; Del Conte A; Tilli M; Rossi S; Ballardini P; Turrisi G; Benea G
In Vivo; 2009; 23(1):131-7. PubMed ID: 19368137
[TBL] [Abstract][Full Text] [Related]
18. Transcatheter arterial chemoembolization (TACE) of colorectal cancer liver metastases by irinotecan-eluting microspheres in a salvage patient population.
Huppert P; Wenzel T; Wietholtz H
Cardiovasc Intervent Radiol; 2014 Feb; 37(1):154-64. PubMed ID: 23670568
[TBL] [Abstract][Full Text] [Related]
19. Preparation of Radiopaque Drug-Eluting Beads for Transcatheter Chemoembolization.
Johnson CG; Tang Y; Beck A; Dreher MR; Woods DL; Negussie AH; Donahue D; Levy EB; Willis SL; Lewis AL; Wood BJ; Sharma KV
J Vasc Interv Radiol; 2016 Jan; 27(1):117-126.e3. PubMed ID: 26549370
[TBL] [Abstract][Full Text] [Related]
20. CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study.
Wu B; Zhou J; Ling G; Zhu D; Long Q
World J Surg Oncol; 2018 Mar; 16(1):69. PubMed ID: 29587773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]